Prediction of optimum compositions of parenteral nanoemulsion system loaded with low solubility drug for treatment of schizophrenia by artificial neural network by Samiun, Wan Sarah et al.
Prediction of optimum compositions of parenteral nanoemulsion system loaded low 
water solubility drug for treatment of schizophrenia by artificial neural networks 
ABSTRACT 
Aripiprazole was encapsulated in the palm kernel oil esters nanoemulsion for the purpose of 
brain delivery via intravenous administration. High shear and high pressure homogenizers 
were applied for formulating low solubility drug in the nanoemulsion system and stabilized 
by different emulsifiers; lecithin, Tween 80 and glycerol. The artificial neural networks 
(ANNs) modeling of nanoemulsion formulation was carried out to achieve the minimum 
particle size. The effects of palm kernel oil ester (PKOE) (3-6%, w/w), lecithin (2-3%, w/w), 
Tween 80 (0.5-1%, w/w), glycerol (1.5-3%, w/w), and water (87-93%, w/w) amounts on the 
particle size were considered as inputs of the network trained. The particle size of samples in 
various compositions was measured as output. To obtain the optimum topologies, ANNs 
were trained by Incremental Back Propagation (IBP), Genetic Algorithm (GA), Batch Back 
Propagation (BBP), Quick Propagation (QP), and Levenberg-Marquardt (LM) algorithms for 
testing data set. The topologies were determined by the indicator of minimized root mean 
squared error (RMSE) for each algorithm. According to the results, the QP-5-4-1, GA-5-12-1, 
IBP-5-11-1, BBP-5-10-1, and LM-5-9-1 were selected as the optimized topologies. It was 
found that the optimal algorithm and topology were the quick propagation and the 
configuration with 5 inputs, 4 hidden and 1 output nodes, respectively. Conclusively, ANN 
models were developed for the prediction of particle size of nanoemulsions loaded with 
aripiprazole and stable nanoemulsion system which could be used effectively for intravenous 
administration.  
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